nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—DRD2—nicotine dependence	0.633	1	CbGaD
Paliperidone—Middle insomnia—Varenicline—nicotine dependence	0.0102	0.0494	CcSEcCtD
Paliperidone—Initial insomnia—Varenicline—nicotine dependence	0.00918	0.0444	CcSEcCtD
Paliperidone—Restless legs syndrome—Varenicline—nicotine dependence	0.00587	0.0284	CcSEcCtD
Paliperidone—Joint stiffness—Varenicline—nicotine dependence	0.00555	0.0268	CcSEcCtD
Paliperidone—Polydipsia—Varenicline—nicotine dependence	0.00541	0.0262	CcSEcCtD
Paliperidone—Respiratory tract congestion—Varenicline—nicotine dependence	0.0046	0.0222	CcSEcCtD
Paliperidone—Drug withdrawal syndrome—Varenicline—nicotine dependence	0.00342	0.0165	CcSEcCtD
Paliperidone—Transient ischaemic attack—Varenicline—nicotine dependence	0.00332	0.0161	CcSEcCtD
Paliperidone—Extrapyramidal symptoms—Varenicline—nicotine dependence	0.00323	0.0156	CcSEcCtD
Paliperidone—Suicide—Varenicline—nicotine dependence	0.00323	0.0156	CcSEcCtD
Paliperidone—Balance disorder—Varenicline—nicotine dependence	0.00307	0.0148	CcSEcCtD
Paliperidone—Sexual dysfunction—Varenicline—nicotine dependence	0.00299	0.0145	CcSEcCtD
Paliperidone—Completed suicide—Varenicline—nicotine dependence	0.00285	0.0138	CcSEcCtD
Paliperidone—Vaginal discharge—Varenicline—nicotine dependence	0.00276	0.0133	CcSEcCtD
Paliperidone—Toothache—Varenicline—nicotine dependence	0.00276	0.0133	CcSEcCtD
Paliperidone—Upset stomach—Varenicline—nicotine dependence	0.00256	0.0124	CcSEcCtD
Paliperidone—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.00256	0.0124	CcSEcCtD
Paliperidone—Risperidone—DRD2—nicotine dependence	0.00253	0.516	CrCbGaD
Paliperidone—Pharyngolaryngeal pain—Varenicline—nicotine dependence	0.00248	0.012	CcSEcCtD
Paliperidone—Intestinal obstruction—Varenicline—nicotine dependence	0.00246	0.0119	CcSEcCtD
Paliperidone—Menstrual disorder—Varenicline—nicotine dependence	0.00246	0.0119	CcSEcCtD
Paliperidone—Laryngeal pain—Varenicline—nicotine dependence	0.00246	0.0119	CcSEcCtD
Paliperidone—Suicidal ideation—Varenicline—nicotine dependence	0.00239	0.0116	CcSEcCtD
Paliperidone—Iloperidone—DRD2—nicotine dependence	0.00237	0.484	CrCbGaD
Paliperidone—Mania—Varenicline—nicotine dependence	0.00231	0.0111	CcSEcCtD
Paliperidone—Menorrhagia—Varenicline—nicotine dependence	0.00227	0.011	CcSEcCtD
Paliperidone—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00223	0.0108	CcSEcCtD
Paliperidone—Glycosuria—Varenicline—nicotine dependence	0.00207	0.01	CcSEcCtD
Paliperidone—Dysphonia—Varenicline—nicotine dependence	0.00204	0.00986	CcSEcCtD
Paliperidone—Endocrine disorder—Varenicline—nicotine dependence	0.00202	0.00978	CcSEcCtD
Paliperidone—Acne—Varenicline—nicotine dependence	0.00199	0.00964	CcSEcCtD
Paliperidone—Disturbance in attention—Varenicline—nicotine dependence	0.00194	0.00936	CcSEcCtD
Paliperidone—Aggression—Varenicline—nicotine dependence	0.00191	0.00923	CcSEcCtD
Paliperidone—Chest discomfort—Varenicline—nicotine dependence	0.0019	0.00916	CcSEcCtD
Paliperidone—Viral infection—Varenicline—nicotine dependence	0.00186	0.00898	CcSEcCtD
Paliperidone—Lacrimation increased—Varenicline—nicotine dependence	0.00182	0.0088	CcSEcCtD
Paliperidone—Dysarthria—Varenicline—nicotine dependence	0.00177	0.00857	CcSEcCtD
Paliperidone—DRD4—brain—nicotine dependence	0.00176	0.0706	CbGeAlD
Paliperidone—Coordination abnormal—Varenicline—nicotine dependence	0.00171	0.00826	CcSEcCtD
Paliperidone—Musculoskeletal pain—Varenicline—nicotine dependence	0.0017	0.00821	CcSEcCtD
Paliperidone—Pulmonary embolism—Varenicline—nicotine dependence	0.00168	0.00811	CcSEcCtD
Paliperidone—Blood pressure increased—Varenicline—nicotine dependence	0.00168	0.00811	CcSEcCtD
Paliperidone—Salivary hypersecretion—Varenicline—nicotine dependence	0.00163	0.00787	CcSEcCtD
Paliperidone—Nightmare—Varenicline—nicotine dependence	0.00162	0.00783	CcSEcCtD
Paliperidone—Photophobia—Varenicline—nicotine dependence	0.00157	0.00761	CcSEcCtD
Paliperidone—Dry eye—Varenicline—nicotine dependence	0.00155	0.00749	CcSEcCtD
Paliperidone—Hypertonia—Varenicline—nicotine dependence	0.00147	0.00711	CcSEcCtD
Paliperidone—HTR1B—cardiovascular system—nicotine dependence	0.00146	0.0587	CbGeAlD
Paliperidone—HTR1D—cardiovascular system—nicotine dependence	0.00142	0.0568	CbGeAlD
Paliperidone—DRD1—midbrain—nicotine dependence	0.00141	0.0566	CbGeAlD
Paliperidone—Sleep disorder—Varenicline—nicotine dependence	0.00141	0.0068	CcSEcCtD
Paliperidone—Diabetes mellitus—Varenicline—nicotine dependence	0.0014	0.00677	CcSEcCtD
Paliperidone—Eczema—Varenicline—nicotine dependence	0.00136	0.00655	CcSEcCtD
Paliperidone—Libido decreased—Varenicline—nicotine dependence	0.00131	0.00635	CcSEcCtD
Paliperidone—Increased appetite—Varenicline—nicotine dependence	0.0013	0.00626	CcSEcCtD
Paliperidone—Atrial fibrillation—Varenicline—nicotine dependence	0.00128	0.00621	CcSEcCtD
Paliperidone—Thirst—Varenicline—nicotine dependence	0.00128	0.00618	CcSEcCtD
Paliperidone—Hypoglycaemia—Varenicline—nicotine dependence	0.00125	0.00603	CcSEcCtD
Paliperidone—Lethargy—Varenicline—nicotine dependence	0.00124	0.00601	CcSEcCtD
Paliperidone—Cerebrovascular accident—Varenicline—nicotine dependence	0.00124	0.00601	CcSEcCtD
Paliperidone—DRD3—brain—nicotine dependence	0.00124	0.0496	CbGeAlD
Paliperidone—Osteoarthritis—Varenicline—nicotine dependence	0.00122	0.00589	CcSEcCtD
Paliperidone—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00121	0.00584	CcSEcCtD
Paliperidone—HTR1A—cardiovascular system—nicotine dependence	0.00118	0.0474	CbGeAlD
Paliperidone—Urinary retention—Varenicline—nicotine dependence	0.00116	0.0056	CcSEcCtD
Paliperidone—HTR1B—midbrain—nicotine dependence	0.00114	0.0458	CbGeAlD
Paliperidone—Dry skin—Varenicline—nicotine dependence	0.00112	0.00539	CcSEcCtD
Paliperidone—Abdominal pain upper—Varenicline—nicotine dependence	0.00111	0.00538	CcSEcCtD
Paliperidone—HTR1D—midbrain—nicotine dependence	0.00111	0.0444	CbGeAlD
Paliperidone—Breast disorder—Varenicline—nicotine dependence	0.0011	0.00532	CcSEcCtD
Paliperidone—HTR2C—midbrain—nicotine dependence	0.0011	0.0439	CbGeAlD
Paliperidone—ADRA1A—cardiovascular system—nicotine dependence	0.00109	0.0437	CbGeAlD
Paliperidone—Nasopharyngitis—Varenicline—nicotine dependence	0.00109	0.00526	CcSEcCtD
Paliperidone—Dysphagia—Varenicline—nicotine dependence	0.00105	0.00509	CcSEcCtD
Paliperidone—Bronchitis—Varenicline—nicotine dependence	0.00101	0.00489	CcSEcCtD
Paliperidone—Abdominal discomfort—Varenicline—nicotine dependence	0.00101	0.00488	CcSEcCtD
Paliperidone—Pollakiuria—Varenicline—nicotine dependence	0.000972	0.0047	CcSEcCtD
Paliperidone—Erectile dysfunction—Varenicline—nicotine dependence	0.000969	0.00469	CcSEcCtD
Paliperidone—Weight increased—Varenicline—nicotine dependence	0.000958	0.00463	CcSEcCtD
Paliperidone—ADRA1B—brain—nicotine dependence	0.000951	0.0381	CbGeAlD
Paliperidone—Hyperglycaemia—Varenicline—nicotine dependence	0.000949	0.00459	CcSEcCtD
Paliperidone—Infestation—Varenicline—nicotine dependence	0.000938	0.00454	CcSEcCtD
Paliperidone—Infestation NOS—Varenicline—nicotine dependence	0.000938	0.00454	CcSEcCtD
Paliperidone—Depression—Varenicline—nicotine dependence	0.000936	0.00452	CcSEcCtD
Paliperidone—HTR1A—midbrain—nicotine dependence	0.000923	0.037	CbGeAlD
Paliperidone—Conjunctivitis—Varenicline—nicotine dependence	0.000912	0.00441	CcSEcCtD
Paliperidone—Hepatobiliary disease—Varenicline—nicotine dependence	0.000888	0.00429	CcSEcCtD
Paliperidone—DRD1—brain—nicotine dependence	0.000887	0.0355	CbGeAlD
Paliperidone—Epistaxis—Varenicline—nicotine dependence	0.000885	0.00428	CcSEcCtD
Paliperidone—Sinusitis—Varenicline—nicotine dependence	0.00088	0.00426	CcSEcCtD
Paliperidone—Bradycardia—Varenicline—nicotine dependence	0.000858	0.00415	CcSEcCtD
Paliperidone—Hypoaesthesia—Varenicline—nicotine dependence	0.000838	0.00405	CcSEcCtD
Paliperidone—DRD2—midbrain—nicotine dependence	0.000834	0.0334	CbGeAlD
Paliperidone—Urinary tract disorder—Varenicline—nicotine dependence	0.000832	0.00402	CcSEcCtD
Paliperidone—Oedema peripheral—Varenicline—nicotine dependence	0.00083	0.00401	CcSEcCtD
Paliperidone—Connective tissue disorder—Varenicline—nicotine dependence	0.000828	0.004	CcSEcCtD
Paliperidone—Urethral disorder—Varenicline—nicotine dependence	0.000826	0.00399	CcSEcCtD
Paliperidone—ADRA2C—midbrain—nicotine dependence	0.00081	0.0325	CbGeAlD
Paliperidone—Eye disorder—Varenicline—nicotine dependence	0.000787	0.00381	CcSEcCtD
Paliperidone—Tinnitus—Varenicline—nicotine dependence	0.000785	0.0038	CcSEcCtD
Paliperidone—Cardiac disorder—Varenicline—nicotine dependence	0.000782	0.00378	CcSEcCtD
Paliperidone—Angiopathy—Varenicline—nicotine dependence	0.000764	0.00369	CcSEcCtD
Paliperidone—Immune system disorder—Varenicline—nicotine dependence	0.000761	0.00368	CcSEcCtD
Paliperidone—Mediastinal disorder—Varenicline—nicotine dependence	0.000759	0.00367	CcSEcCtD
Paliperidone—Chills—Varenicline—nicotine dependence	0.000756	0.00365	CcSEcCtD
Paliperidone—Mental disorder—Varenicline—nicotine dependence	0.000738	0.00357	CcSEcCtD
Paliperidone—Malnutrition—Varenicline—nicotine dependence	0.000733	0.00354	CcSEcCtD
Paliperidone—Erythema—Varenicline—nicotine dependence	0.000733	0.00354	CcSEcCtD
Paliperidone—Flatulence—Varenicline—nicotine dependence	0.000723	0.00349	CcSEcCtD
Paliperidone—HTR1B—brain—nicotine dependence	0.000718	0.0288	CbGeAlD
Paliperidone—Dysgeusia—Varenicline—nicotine dependence	0.000718	0.00347	CcSEcCtD
Paliperidone—Back pain—Varenicline—nicotine dependence	0.000709	0.00343	CcSEcCtD
Paliperidone—Muscle spasms—Varenicline—nicotine dependence	0.000705	0.00341	CcSEcCtD
Paliperidone—HTR2A—cardiovascular system—nicotine dependence	0.000704	0.0282	CbGeAlD
Paliperidone—HTR1D—brain—nicotine dependence	0.000696	0.0279	CbGeAlD
Paliperidone—Vision blurred—Varenicline—nicotine dependence	0.000691	0.00334	CcSEcCtD
Paliperidone—HTR2C—brain—nicotine dependence	0.000689	0.0276	CbGeAlD
Paliperidone—Tremor—Varenicline—nicotine dependence	0.000687	0.00332	CcSEcCtD
Paliperidone—Ill-defined disorder—Varenicline—nicotine dependence	0.00068	0.00329	CcSEcCtD
Paliperidone—Anaemia—Varenicline—nicotine dependence	0.000678	0.00328	CcSEcCtD
Paliperidone—Agitation—Varenicline—nicotine dependence	0.000674	0.00326	CcSEcCtD
Paliperidone—Angioedema—Varenicline—nicotine dependence	0.00067	0.00324	CcSEcCtD
Paliperidone—Malaise—Varenicline—nicotine dependence	0.000661	0.0032	CcSEcCtD
Paliperidone—Vertigo—Varenicline—nicotine dependence	0.000659	0.00318	CcSEcCtD
Paliperidone—Syncope—Varenicline—nicotine dependence	0.000658	0.00318	CcSEcCtD
Paliperidone—Palpitations—Varenicline—nicotine dependence	0.000648	0.00313	CcSEcCtD
Paliperidone—ADRA2A—midbrain—nicotine dependence	0.000647	0.0259	CbGeAlD
Paliperidone—Loss of consciousness—Varenicline—nicotine dependence	0.000645	0.00312	CcSEcCtD
Paliperidone—Cough—Varenicline—nicotine dependence	0.00064	0.00309	CcSEcCtD
Paliperidone—Convulsion—Varenicline—nicotine dependence	0.000635	0.00307	CcSEcCtD
Paliperidone—Hypertension—Varenicline—nicotine dependence	0.000633	0.00306	CcSEcCtD
Paliperidone—Myalgia—Varenicline—nicotine dependence	0.000624	0.00302	CcSEcCtD
Paliperidone—Chest pain—Varenicline—nicotine dependence	0.000624	0.00302	CcSEcCtD
Paliperidone—Arthralgia—Varenicline—nicotine dependence	0.000624	0.00302	CcSEcCtD
Paliperidone—Anxiety—Varenicline—nicotine dependence	0.000622	0.00301	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00062	0.003	CcSEcCtD
Paliperidone—Discomfort—Varenicline—nicotine dependence	0.000617	0.00298	CcSEcCtD
Paliperidone—Dry mouth—Varenicline—nicotine dependence	0.000611	0.00295	CcSEcCtD
Paliperidone—Oedema—Varenicline—nicotine dependence	0.000599	0.00289	CcSEcCtD
Paliperidone—Infection—Varenicline—nicotine dependence	0.000595	0.00287	CcSEcCtD
Paliperidone—Shock—Varenicline—nicotine dependence	0.000589	0.00285	CcSEcCtD
Paliperidone—Nervous system disorder—Varenicline—nicotine dependence	0.000587	0.00284	CcSEcCtD
Paliperidone—Thrombocytopenia—Varenicline—nicotine dependence	0.000586	0.00283	CcSEcCtD
Paliperidone—Tachycardia—Varenicline—nicotine dependence	0.000584	0.00282	CcSEcCtD
Paliperidone—Skin disorder—Varenicline—nicotine dependence	0.000581	0.00281	CcSEcCtD
Paliperidone—HTR1A—brain—nicotine dependence	0.00058	0.0232	CbGeAlD
Paliperidone—Anorexia—Varenicline—nicotine dependence	0.00057	0.00276	CcSEcCtD
Paliperidone—Hypotension—Varenicline—nicotine dependence	0.000559	0.0027	CcSEcCtD
Paliperidone—HTR2A—midbrain—nicotine dependence	0.00055	0.022	CbGeAlD
Paliperidone—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.000545	0.00264	CcSEcCtD
Paliperidone—Insomnia—Varenicline—nicotine dependence	0.000541	0.00262	CcSEcCtD
Paliperidone—ADRA1A—brain—nicotine dependence	0.000534	0.0214	CbGeAlD
Paliperidone—Dyspnoea—Varenicline—nicotine dependence	0.000534	0.00258	CcSEcCtD
Paliperidone—Somnolence—Varenicline—nicotine dependence	0.000532	0.00257	CcSEcCtD
Paliperidone—Dyspepsia—Varenicline—nicotine dependence	0.000527	0.00255	CcSEcCtD
Paliperidone—DRD2—brain—nicotine dependence	0.000524	0.021	CbGeAlD
Paliperidone—Decreased appetite—Varenicline—nicotine dependence	0.00052	0.00251	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Varenicline—nicotine dependence	0.000517	0.0025	CcSEcCtD
Paliperidone—Fatigue—Varenicline—nicotine dependence	0.000516	0.00249	CcSEcCtD
Paliperidone—Constipation—Varenicline—nicotine dependence	0.000512	0.00247	CcSEcCtD
Paliperidone—Pain—Varenicline—nicotine dependence	0.000512	0.00247	CcSEcCtD
Paliperidone—ADRA2C—brain—nicotine dependence	0.000509	0.0204	CbGeAlD
Paliperidone—Feeling abnormal—Varenicline—nicotine dependence	0.000493	0.00238	CcSEcCtD
Paliperidone—Gastrointestinal pain—Varenicline—nicotine dependence	0.000489	0.00237	CcSEcCtD
Paliperidone—Urticaria—Varenicline—nicotine dependence	0.000475	0.0023	CcSEcCtD
Paliperidone—Body temperature increased—Varenicline—nicotine dependence	0.000473	0.00229	CcSEcCtD
Paliperidone—Abdominal pain—Varenicline—nicotine dependence	0.000473	0.00229	CcSEcCtD
Paliperidone—Hypersensitivity—Varenicline—nicotine dependence	0.000441	0.00213	CcSEcCtD
Paliperidone—Asthenia—Varenicline—nicotine dependence	0.000429	0.00208	CcSEcCtD
Paliperidone—Pruritus—Varenicline—nicotine dependence	0.000423	0.00205	CcSEcCtD
Paliperidone—HRH1—brain—nicotine dependence	0.000414	0.0166	CbGeAlD
Paliperidone—Diarrhoea—Varenicline—nicotine dependence	0.000409	0.00198	CcSEcCtD
Paliperidone—ADRA2A—brain—nicotine dependence	0.000406	0.0163	CbGeAlD
Paliperidone—Dizziness—Varenicline—nicotine dependence	0.000396	0.00191	CcSEcCtD
Paliperidone—Vomiting—Varenicline—nicotine dependence	0.000381	0.00184	CcSEcCtD
Paliperidone—Rash—Varenicline—nicotine dependence	0.000377	0.00182	CcSEcCtD
Paliperidone—Dermatitis—Varenicline—nicotine dependence	0.000377	0.00182	CcSEcCtD
Paliperidone—Headache—Varenicline—nicotine dependence	0.000375	0.00181	CcSEcCtD
Paliperidone—Nausea—Varenicline—nicotine dependence	0.000356	0.00172	CcSEcCtD
Paliperidone—HTR2A—brain—nicotine dependence	0.000346	0.0139	CbGeAlD
Paliperidone—CYP2D6—brain—nicotine dependence	0.000315	0.0126	CbGeAlD
Paliperidone—DRD2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000148	0.00113	CbGpPWpGaD
Paliperidone—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000148	0.00113	CbGpPWpGaD
Paliperidone—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000147	0.00113	CbGpPWpGaD
Paliperidone—DRD3—GPCR ligand binding—OPRM1—nicotine dependence	0.000147	0.00113	CbGpPWpGaD
Paliperidone—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000145	0.00111	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000145	0.00111	CbGpPWpGaD
Paliperidone—HRH1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000145	0.00111	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—FGD1—nicotine dependence	0.000142	0.00109	CbGpPWpGaD
Paliperidone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000142	0.00109	CbGpPWpGaD
Paliperidone—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000142	0.00109	CbGpPWpGaD
Paliperidone—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000141	0.00108	CbGpPWpGaD
Paliperidone—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000141	0.00108	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—FGD1—nicotine dependence	0.00014	0.00108	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—FGD1—nicotine dependence	0.00014	0.00107	CbGpPWpGaD
Paliperidone—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00014	0.00107	CbGpPWpGaD
Paliperidone—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000139	0.00107	CbGpPWpGaD
Paliperidone—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000137	0.00105	CbGpPWpGaD
Paliperidone—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000137	0.00105	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000137	0.00105	CbGpPWpGaD
Paliperidone—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000135	0.00104	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000135	0.00103	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000135	0.00103	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000135	0.00103	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000134	0.00103	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—FGD1—nicotine dependence	0.000134	0.00103	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR ligand binding—OPRM1—nicotine dependence	0.000133	0.00102	CbGpPWpGaD
Paliperidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000132	0.00101	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000132	0.00101	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—FGD1—nicotine dependence	0.00013	0.000999	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—FGD1—nicotine dependence	0.000128	0.000984	CbGpPWpGaD
Paliperidone—HTR1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000128	0.000982	CbGpPWpGaD
Paliperidone—HTR2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000127	0.000977	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—FGD1—nicotine dependence	0.000127	0.000972	CbGpPWpGaD
Paliperidone—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000126	0.000966	CbGpPWpGaD
Paliperidone—HTR1D—GPCR ligand binding—DRD2—nicotine dependence	0.000124	0.000952	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000124	0.00095	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TAS2R16—nicotine dependence	0.000124	0.000947	CbGpPWpGaD
Paliperidone—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000123	0.00094	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000123	0.000939	CbGpPWpGaD
Paliperidone—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000122	0.000938	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—FGD1—nicotine dependence	0.000122	0.000938	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR ligand binding—OPRM1—nicotine dependence	0.000122	0.000935	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—FGD1—nicotine dependence	0.000122	0.000933	CbGpPWpGaD
Paliperidone—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000122	0.000932	CbGpPWpGaD
Paliperidone—HTR1B—GPCR ligand binding—DRD2—nicotine dependence	0.000122	0.000932	CbGpPWpGaD
Paliperidone—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000121	0.000927	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TAS2R16—nicotine dependence	0.000121	0.000927	CbGpPWpGaD
Paliperidone—ADRA2A—G alpha (i) signalling events—DRD2—nicotine dependence	0.00012	0.000921	CbGpPWpGaD
Paliperidone—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00012	0.00092	CbGpPWpGaD
Paliperidone—DRD4—GPCR ligand binding—DRD2—nicotine dependence	0.00012	0.000917	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TAS2R16—nicotine dependence	0.000119	0.000912	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—FGD1—nicotine dependence	0.000118	0.000907	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.000118	0.000907	CbGpPWpGaD
Paliperidone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000118	0.000902	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—FGD1—nicotine dependence	0.000117	0.000893	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000116	0.000892	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—FGD1—nicotine dependence	0.000116	0.00089	CbGpPWpGaD
Paliperidone—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000116	0.000888	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000114	0.000874	CbGpPWpGaD
Paliperidone—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	0.000113	0.000862	CbGpPWpGaD
Paliperidone—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000112	0.000855	CbGpPWpGaD
Paliperidone—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000111	0.000848	CbGpPWpGaD
Paliperidone—HRH1—GPCR ligand binding—OPRM1—nicotine dependence	0.00011	0.000846	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000108	0.00083	CbGpPWpGaD
Paliperidone—DRD1—GPCR ligand binding—DRD2—nicotine dependence	0.000108	0.000825	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—FGD1—nicotine dependence	0.000107	0.000823	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TAS2R16—nicotine dependence	0.000107	0.000821	CbGpPWpGaD
Paliperidone—DRD3—GPCR ligand binding—DRD2—nicotine dependence	0.000106	0.000814	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000106	0.000812	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	0.000106	0.00081	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TAS2R16—nicotine dependence	0.000106	0.00081	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—FGD1—nicotine dependence	0.000106	0.000808	CbGpPWpGaD
Paliperidone—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000105	0.000805	CbGpPWpGaD
Paliperidone—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000105	0.000804	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	0.000104	0.000793	CbGpPWpGaD
Paliperidone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000103	0.000788	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000101	0.000772	CbGpPWpGaD
Paliperidone—HTR1D—GPCR downstream signaling—OPRM1—nicotine dependence	9.71e-05	0.000744	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—FGD1—nicotine dependence	9.69e-05	0.000743	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—FGD1—nicotine dependence	9.62e-05	0.000737	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR ligand binding—DRD2—nicotine dependence	9.6e-05	0.000735	CbGpPWpGaD
Paliperidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	9.56e-05	0.000733	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TAS2R16—nicotine dependence	9.55e-05	0.000731	CbGpPWpGaD
Paliperidone—HTR1B—GPCR downstream signaling—OPRM1—nicotine dependence	9.51e-05	0.000728	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—FGD1—nicotine dependence	9.49e-05	0.000727	CbGpPWpGaD
Paliperidone—DRD4—GPCR downstream signaling—OPRM1—nicotine dependence	9.35e-05	0.000717	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—FGD1—nicotine dependence	9.34e-05	0.000716	CbGpPWpGaD
Paliperidone—HTR1A—GPCR ligand binding—DRD2—nicotine dependence	9.26e-05	0.00071	CbGpPWpGaD
Paliperidone—HTR2C—GPCR ligand binding—DRD2—nicotine dependence	9.22e-05	0.000706	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TAS2R16—nicotine dependence	9.21e-05	0.000706	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TAS2R16—nicotine dependence	9.17e-05	0.000702	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR ligand binding—DRD2—nicotine dependence	8.96e-05	0.000687	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TAS2R16—nicotine dependence	8.92e-05	0.000683	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR ligand binding—DRD2—nicotine dependence	8.82e-05	0.000676	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—OPRM1—nicotine dependence	8.82e-05	0.000675	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TAS2R16—nicotine dependence	8.78e-05	0.000672	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—OPRM1—nicotine dependence	8.63e-05	0.000661	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—AKR1B10—nicotine dependence	8.56e-05	0.000656	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—OPRM1—nicotine dependence	8.49e-05	0.000651	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—OPRM1—nicotine dependence	8.42e-05	0.000645	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—FGD1—nicotine dependence	8.41e-05	0.000644	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—AKR1B10—nicotine dependence	8.38e-05	0.000642	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—OPRM1—nicotine dependence	8.31e-05	0.000637	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—FGD1—nicotine dependence	8.3e-05	0.000636	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—AKR1B10—nicotine dependence	8.25e-05	0.000632	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	8.09e-05	0.00062	CbGpPWpGaD
Paliperidone—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	8e-05	0.000613	CbGpPWpGaD
Paliperidone—HRH1—GPCR ligand binding—DRD2—nicotine dependence	7.99e-05	0.000612	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	7.96e-05	0.00061	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TAS2R16—nicotine dependence	7.94e-05	0.000609	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	7.84e-05	0.0006	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	7.79e-05	0.000597	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—OPRM1—nicotine dependence	7.65e-05	0.000586	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—OPRM1—nicotine dependence	7.55e-05	0.000578	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—OPRM1—nicotine dependence	7.5e-05	0.000575	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—FGD1—nicotine dependence	7.49e-05	0.000574	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—AKR1B10—nicotine dependence	7.43e-05	0.000569	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—AKR1B10—nicotine dependence	7.33e-05	0.000562	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	7.28e-05	0.000558	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	7.24e-05	0.000555	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	7.24e-05	0.000555	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—FGD1—nicotine dependence	7.23e-05	0.000554	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	7.2e-05	0.000552	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—FGD1—nicotine dependence	7.19e-05	0.000551	CbGpPWpGaD
Paliperidone—HTR1D—GPCR downstream signaling—DRD2—nicotine dependence	7.02e-05	0.000538	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—OPRM1—nicotine dependence	7.01e-05	0.000537	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—FGD1—nicotine dependence	7e-05	0.000536	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—OPRM1—nicotine dependence	6.9e-05	0.000528	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—FGD1—nicotine dependence	6.89e-05	0.000528	CbGpPWpGaD
Paliperidone—HTR1B—GPCR downstream signaling—DRD2—nicotine dependence	6.87e-05	0.000527	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—CYP2A7—nicotine dependence	6.87e-05	0.000526	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—OPRM1—nicotine dependence	6.81e-05	0.000522	CbGpPWpGaD
Paliperidone—DRD4—GPCR downstream signaling—DRD2—nicotine dependence	6.76e-05	0.000518	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—AKR1B10—nicotine dependence	6.62e-05	0.000507	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	6.58e-05	0.000504	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	6.54e-05	0.000501	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	6.39e-05	0.000489	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—DRD2—nicotine dependence	6.37e-05	0.000488	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—OPRM1—nicotine dependence	6.36e-05	0.000488	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	6.36e-05	0.000487	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	6.35e-05	0.000487	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—FGD1—nicotine dependence	6.35e-05	0.000486	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—OPRM1—nicotine dependence	6.26e-05	0.00048	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	6.26e-05	0.000479	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—FGD1—nicotine dependence	6.25e-05	0.000479	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—OPRM1—nicotine dependence	6.24e-05	0.000478	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—DRD2—nicotine dependence	6.24e-05	0.000478	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—FGD1—nicotine dependence	6.23e-05	0.000478	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—AKR1B10—nicotine dependence	6.18e-05	0.000474	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—DRD2—nicotine dependence	6.14e-05	0.000471	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	6.13e-05	0.000469	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	6.12e-05	0.000469	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—DRD2—nicotine dependence	6.09e-05	0.000466	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—AKR1B10—nicotine dependence	6.08e-05	0.000466	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—WASF2—nicotine dependence	6.03e-05	0.000462	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—DRD2—nicotine dependence	6.01e-05	0.00046	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—WASF2—nicotine dependence	5.91e-05	0.000453	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—WASF2—nicotine dependence	5.81e-05	0.000445	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—WASF1—nicotine dependence	5.78e-05	0.000443	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	5.77e-05	0.000442	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	5.69e-05	0.000436	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	5.68e-05	0.000435	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	5.68e-05	0.000435	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—OPRM1—nicotine dependence	5.67e-05	0.000434	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—WASF1—nicotine dependence	5.66e-05	0.000434	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	5.61e-05	0.00043	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—CYP2A7—nicotine dependence	5.58e-05	0.000428	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—WASF1—nicotine dependence	5.57e-05	0.000427	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	5.56e-05	0.000426	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—DRD2—nicotine dependence	5.53e-05	0.000424	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	5.52e-05	0.000423	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—AKR1B10—nicotine dependence	5.51e-05	0.000422	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—DRD2—nicotine dependence	5.46e-05	0.000418	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—DRD2—nicotine dependence	5.42e-05	0.000416	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	5.4e-05	0.000414	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	5.24e-05	0.000401	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—WASF2—nicotine dependence	5.23e-05	0.000401	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	5.21e-05	0.000399	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—OPRM1—nicotine dependence	5.21e-05	0.000399	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	5.17e-05	0.000396	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—WASF2—nicotine dependence	5.16e-05	0.000396	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—CYP2A7—nicotine dependence	5.11e-05	0.000392	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—OPRM1—nicotine dependence	5.1e-05	0.000391	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—DRD2—nicotine dependence	5.07e-05	0.000388	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	5.02e-05	0.000385	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—OPRM1—nicotine dependence	5.02e-05	0.000384	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—WASF1—nicotine dependence	5.02e-05	0.000384	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—DRD2—nicotine dependence	4.99e-05	0.000382	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—WASF1—nicotine dependence	4.95e-05	0.000379	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—DRD2—nicotine dependence	4.92e-05	0.000377	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	4.75e-05	0.000364	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	4.73e-05	0.000362	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—WASF2—nicotine dependence	4.66e-05	0.000357	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—DRD2—nicotine dependence	4.6e-05	0.000352	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—DRD2—nicotine dependence	4.53e-05	0.000347	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	4.52e-05	0.000347	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—OPRM1—nicotine dependence	4.52e-05	0.000346	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—DRD2—nicotine dependence	4.51e-05	0.000346	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—WASF2—nicotine dependence	4.5e-05	0.000345	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—WASF2—nicotine dependence	4.48e-05	0.000343	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—WASF1—nicotine dependence	4.47e-05	0.000342	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—OPRM1—nicotine dependence	4.46e-05	0.000342	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	4.43e-05	0.000339	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—WASF2—nicotine dependence	4.35e-05	0.000334	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—WASF1—nicotine dependence	4.31e-05	0.000331	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—WASF1—nicotine dependence	4.29e-05	0.000329	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—WASF2—nicotine dependence	4.29e-05	0.000328	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—WASF1—nicotine dependence	4.17e-05	0.00032	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	4.11e-05	0.000315	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—WASF1—nicotine dependence	4.11e-05	0.000315	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	4.11e-05	0.000315	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—DRD2—nicotine dependence	4.1e-05	0.000314	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—OPRM1—nicotine dependence	4.02e-05	0.000308	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	4.02e-05	0.000308	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—WASF2—nicotine dependence	3.95e-05	0.000303	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—WASF2—nicotine dependence	3.89e-05	0.000298	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	3.88e-05	0.000298	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—WASF2—nicotine dependence	3.88e-05	0.000297	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	3.86e-05	0.000296	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	3.81e-05	0.000292	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—WASF1—nicotine dependence	3.79e-05	0.00029	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—DRD2—nicotine dependence	3.77e-05	0.000288	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—OPRM1—nicotine dependence	3.76e-05	0.000288	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	3.74e-05	0.000286	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—WASF1—nicotine dependence	3.73e-05	0.000286	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—WASF1—nicotine dependence	3.72e-05	0.000285	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—OPRM1—nicotine dependence	3.7e-05	0.000283	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—DRD2—nicotine dependence	3.69e-05	0.000282	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	3.65e-05	0.00028	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—CYP2A7—nicotine dependence	3.64e-05	0.000279	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—DRD2—nicotine dependence	3.63e-05	0.000278	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	3.54e-05	0.000271	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—OPRM1—nicotine dependence	3.41e-05	0.000261	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	3.39e-05	0.00026	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	3.36e-05	0.000257	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—OPRM1—nicotine dependence	3.35e-05	0.000257	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	3.29e-05	0.000252	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—DRD2—nicotine dependence	3.27e-05	0.00025	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—DRD2—nicotine dependence	3.22e-05	0.000247	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	3.05e-05	0.000234	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—DRD2—nicotine dependence	2.91e-05	0.000223	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—DRD2—nicotine dependence	2.81e-05	0.000215	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—DRD2—nicotine dependence	2.79e-05	0.000214	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—DRD2—nicotine dependence	2.72e-05	0.000208	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—DRD2—nicotine dependence	2.67e-05	0.000205	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—DRD2—nicotine dependence	2.43e-05	0.000186	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—DRD2—nicotine dependence	2.42e-05	0.000185	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CYP2A7—nicotine dependence	2.38e-05	0.000182	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	2.38e-05	0.000182	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	2.21e-05	0.000169	CbGpPWpGaD
